![Cancers | Free Full-Text | Large-Scale Proteomic Analysis of Follicular Lymphoma Reveals Extensive Remodeling of Cell Adhesion Pathway and Identifies Hub Proteins Related to the Lymphomagenesis Cancers | Free Full-Text | Large-Scale Proteomic Analysis of Follicular Lymphoma Reveals Extensive Remodeling of Cell Adhesion Pathway and Identifies Hub Proteins Related to the Lymphomagenesis](https://www.mdpi.com/cancers/cancers-13-00630/article_deploy/html/images/cancers-13-00630-g004-550.jpg)
Cancers | Free Full-Text | Large-Scale Proteomic Analysis of Follicular Lymphoma Reveals Extensive Remodeling of Cell Adhesion Pathway and Identifies Hub Proteins Related to the Lymphomagenesis
![Dissecting intratumor heterogeneity of nodal B cell lymphomas on the transcriptional, genetic, and drug response level | bioRxiv Dissecting intratumor heterogeneity of nodal B cell lymphomas on the transcriptional, genetic, and drug response level | bioRxiv](https://www.biorxiv.org/content/biorxiv/early/2019/12/11/850438/F3.large.jpg)
Dissecting intratumor heterogeneity of nodal B cell lymphomas on the transcriptional, genetic, and drug response level | bioRxiv
![Cancers | Free Full-Text | Large-Scale Proteomic Analysis of Follicular Lymphoma Reveals Extensive Remodeling of Cell Adhesion Pathway and Identifies Hub Proteins Related to the Lymphomagenesis Cancers | Free Full-Text | Large-Scale Proteomic Analysis of Follicular Lymphoma Reveals Extensive Remodeling of Cell Adhesion Pathway and Identifies Hub Proteins Related to the Lymphomagenesis](https://www.mdpi.com/cancers/cancers-13-00630/article_deploy/html/images/cancers-13-00630-g006.png)
Cancers | Free Full-Text | Large-Scale Proteomic Analysis of Follicular Lymphoma Reveals Extensive Remodeling of Cell Adhesion Pathway and Identifies Hub Proteins Related to the Lymphomagenesis
![EZH2 mutations at diagnosis in follicular lymphoma: a promising biomarker to guide frontline treatment | BMC Cancer | Full Text EZH2 mutations at diagnosis in follicular lymphoma: a promising biomarker to guide frontline treatment | BMC Cancer | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12885-022-10070-z/MediaObjects/12885_2022_10070_Fig1_HTML.png)
EZH2 mutations at diagnosis in follicular lymphoma: a promising biomarker to guide frontline treatment | BMC Cancer | Full Text
![Male Reproductive Health After Childhood, Adolescent, and Young Adult Cancers: A Report From the Children's Oncology Group | Journal of Clinical Oncology Male Reproductive Health After Childhood, Adolescent, and Young Adult Cancers: A Report From the Children's Oncology Group | Journal of Clinical Oncology](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/jco/2012/jco.2012.44.30.issue-27/jco.2012.44.30.issue-27/20160922/jco.2012.44.30.issue-27.largecover.png)
Male Reproductive Health After Childhood, Adolescent, and Young Adult Cancers: A Report From the Children's Oncology Group | Journal of Clinical Oncology
Patient derived lymphoma spheroids (PDLS) as preclinical follicular lymphoma models for personalized medicine: identification of
![Strategies to improve outcomes of autologous hematopoietic cell transplant in lymphoma | Bone Marrow Transplantation Strategies to improve outcomes of autologous hematopoietic cell transplant in lymphoma | Bone Marrow Transplantation](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41409-018-0378-z/MediaObjects/41409_2018_378_Fig1_HTML.png)
Strategies to improve outcomes of autologous hematopoietic cell transplant in lymphoma | Bone Marrow Transplantation
![NCCN Guidelines Insights: B-Cell Lymphomas, Version 3.2019 in: Journal of the National Comprehensive Cancer Network Volume 17 Issue 6 (2019) NCCN Guidelines Insights: B-Cell Lymphomas, Version 3.2019 in: Journal of the National Comprehensive Cancer Network Volume 17 Issue 6 (2019)](https://jnccn.org/cover/journals/jnccn/17/6/cover.jpg)
NCCN Guidelines Insights: B-Cell Lymphomas, Version 3.2019 in: Journal of the National Comprehensive Cancer Network Volume 17 Issue 6 (2019)
Medical Oncology - Kantarjian, Wolff - The MD Anderson Manual of 2016 | PDF | Doctor Of Medicine | Oncology
![Cancers | Free Full-Text | Large-Scale Proteomic Analysis of Follicular Lymphoma Reveals Extensive Remodeling of Cell Adhesion Pathway and Identifies Hub Proteins Related to the Lymphomagenesis Cancers | Free Full-Text | Large-Scale Proteomic Analysis of Follicular Lymphoma Reveals Extensive Remodeling of Cell Adhesion Pathway and Identifies Hub Proteins Related to the Lymphomagenesis](https://www.mdpi.com/cancers/cancers-13-00630/article_deploy/html/images/cancers-13-00630-g003-550.jpg)
Cancers | Free Full-Text | Large-Scale Proteomic Analysis of Follicular Lymphoma Reveals Extensive Remodeling of Cell Adhesion Pathway and Identifies Hub Proteins Related to the Lymphomagenesis
![Cancers | Free Full-Text | Large-Scale Proteomic Analysis of Follicular Lymphoma Reveals Extensive Remodeling of Cell Adhesion Pathway and Identifies Hub Proteins Related to the Lymphomagenesis Cancers | Free Full-Text | Large-Scale Proteomic Analysis of Follicular Lymphoma Reveals Extensive Remodeling of Cell Adhesion Pathway and Identifies Hub Proteins Related to the Lymphomagenesis](https://www.mdpi.com/cancers/cancers-13-00630/article_deploy/html/images/cancers-13-00630-g001-550.jpg)
Cancers | Free Full-Text | Large-Scale Proteomic Analysis of Follicular Lymphoma Reveals Extensive Remodeling of Cell Adhesion Pathway and Identifies Hub Proteins Related to the Lymphomagenesis
![(PDF) Radiotherapy for Non-Hodgkin's lymphoma: Still standard practice and not an outdated treatment option (PDF) Radiotherapy for Non-Hodgkin's lymphoma: Still standard practice and not an outdated treatment option](https://i1.rgstatic.net/publication/307530733_Radiotherapy_for_Non-Hodgkin's_lymphoma_Still_standard_practice_and_not_an_outdated_treatment_option/links/5fc4d1dea6fdcc6cc6852b7e/largepreview.png)
(PDF) Radiotherapy for Non-Hodgkin's lymphoma: Still standard practice and not an outdated treatment option
![(PDF) EZH2 mutations at diagnosis in follicular lymphoma: a promising biomarker to guide frontline treatment (PDF) EZH2 mutations at diagnosis in follicular lymphoma: a promising biomarker to guide frontline treatment](https://i1.rgstatic.net/publication/363543318_EZH2_mutations_at_diagnosis_in_follicular_lymphoma_a_promising_biomarker_to_guide_frontline_treatment/links/63227495071ea12e36346ecc/largepreview.png)